Sergey Shlyapnikov
Impact in
-
- Nosocomial Infections in ICU
-
- Antibiotic Use and Resistance
Papers in
-
- Antimicrobial Resistance in Staphylococcus 3
- Antifungal resistance and susceptibility 1
- Surgery 2
- Surgical site infection prevention 2
- Co-authors
- Jennifer Townsend (1 shared paper)Péter Kanizsai (1 shared paper)Michael Oppert (1 shared paper)Ricard Ferrer (1 shared paper)Giulio Toccafondi (1 shared paper)Juan González del Castillo (1 shared paper)Mario Plebani (1 shared paper)Andrea Lay‐Hoon Kwa (1 shared paper)
- Journals
- Infectious Diseases and Therapy (2 papers)Clinical Chemistry and Laboratory Medicine (CCLM) (1 paper)Infection Control and Hospital Epidemiology (1 paper)Critical Care Medicine (1 paper)Open Forum Infectious Diseases (1 paper)
- Partner nations
- RussiaUnited KingdomUnited States
In The Last Decade
Sergey Shlyapnikov
8 papers receiving 301 citations
Peers
Comparison fields: 5 of 64
- Critical Care and Intensive Care Medicine 50
- Applied Microbiology and Biotechnology 18
- Epidemiology 149
- Family Practice 8
- Clinical Biochemistry 21
Countries citing papers authored by Sergey Shlyapnikov
This map shows the geographic impact of Sergey Shlyapnikov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sergey Shlyapnikov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sergey Shlyapnikov more than expected).
Fields of papers citing papers by Sergey Shlyapnikov
This network shows the impact of papers produced by Sergey Shlyapnikov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sergey Shlyapnikov. The network helps show where Sergey Shlyapnikov may publish in the future.
Co-authors
The 25 scholars most cited alongside Sergey Shlyapnikov, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 187 | |
| 2 | 2011 | 85 | |
| 3 | 2007 | 18 | |
| 4 | 2022 | 9 | |
| 5 | 2018 | 5 | |
| 6 | 2017 | 4 | |
| 7 | 2020 | 4 | |
| 8 | 2018 | 1 |
About Sergey Shlyapnikov
Sergey Shlyapnikov is a scholar working on Infectious Diseases, Surgery, Genetics, Critical Care and Intensive Care Medicine and Pathology and Forensic Medicine, having authored 8 papers that have together received 313 indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (3 papers), Surgical site infection prevention (2 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (1 paper), Spine and Intervertebral Disc Pathology (1 paper), Acne and Rosacea Treatments and Effects (1 paper), Antifungal resistance and susceptibility (1 paper), Abdominal Surgery and Complications (1 paper) and Sepsis Diagnosis and Treatment (1 paper). The work is most often cited by research in Critical Care and Intensive Care Medicine (50 citations), Applied Microbiology and Biotechnology (18 citations), Epidemiology (149 citations), Family Practice (8 citations) and Clinical Biochemistry (21 citations). Sergey Shlyapnikov has collaborated with scholars based in Russia, United Kingdom and United States. Frequent co-authors include Jennifer Townsend, Péter Kanizsai, Michael Oppert, Ricard Ferrer, Giulio Toccafondi, Juan González del Castillo, Mario Plebani, Andrea Lay‐Hoon Kwa, Jens‐Ulrik Stæhr Jensen and Tobias Welte. Their work appears in journals such as Infectious Diseases and Therapy, Clinical Chemistry and Laboratory Medicine (CCLM), Infection Control and Hospital Epidemiology, Critical Care Medicine and Open Forum Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.